# Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity

> **NCT00999908** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 54 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Indacaterol 150 μg
- **DRUG:** Tiotropium 18 μg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00999908
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00999908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00999908, "Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity". Retrieved via MORVS 2026-10-12 from https://api.morvs.ai/clinical/NCT00999908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*